Organogenesis Holdings Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 03/31/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $564.2 | $482.0 | $433.1 | $450.9 | — |
| Operating income | $44.7 | -$1.3 | $12.5 | $22.3 | — |
| Net income | $37.0 | $0.9 | $4.9 | $15.5 | — |
| Cash Flow Statement | |||||
| Free cash flow | -$24.5 | $4.2 | $6.6 | -$9.0 | — |
| Share repurchases | — | $25.5 | $0.0 | $0.0 | — |
Shares outstanding 128.7M
Annual filing data through FY ended December 31, 2025; float as of September 12, 2026.